BD 8 avr. 2026 FDA clears Onclarity HPV self-collection kit, approves BD Onclarity HPV Assay for cervical cancer screening - Contemporary OB/GYN
BD 24 févr. 2026 Waters Merger With BD Unit Shifts Focus Toward Diagnostics And Valuation - Yahoo Finance
BD 9 févr. 2026 Waters Completes Combination With BD Biosciences, Diagnostic Solutions Businesses - Contract Pharma
BD 9 févr. 2026 BD Reports First Quarter Fiscal 2026 Financial Results :: Becton, Dickinson and Company (BDX) - Becton Dickinson
BD 28 janv. 2026 BD, Waters set completion date for $17.5B biosciences and diagnostics merger - MedTech Dive
BD 27 janv. 2026 BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business - Becton Dickinson
BD 19 janv. 2026 BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026 - BD Newsroom
BD 23 juil. 2025 BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - BD Newsroom
BD 14 juil. 2025 Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing :: Becton, Dickinson and Company (BDX) - Becton Dickinson